Latest filing published 16 Oct 2020 for Altimmune, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -95.6%Entry US$59.40 · Close at T+365 US$2.62
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mitchel Sayare: trading record in brief
This profile gathers the share dealings of Mitchel Sayare across 2 companies, led by ImmunoGen, Inc. and Altimmune, Inc. Between 31 January 2006 and 24 September 2020, the trades on record add up to 91 filings.
On the open market, the record shows 3 purchases worth €140k and 65 sales worth €2.9M. Netting one side against the other leaves €2.8M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 23 option exercises.
In size, the median ticket on the buying side is €8,328.
The record was last updated on 16 October 2020 with an option exercise in Altimmune, Inc. The last purchase on record was published on 3 January 2018, which is 3,231 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mitchel Sayare
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,275 shares0Common Stock, par value $0.0001SEC:0000899243-20-028540:0
- 5,100 shares@ US$1.951.5% of flowCommon Stock, par value $0.0001SEC:0001012975-18-000023:0Canonical exit: 29 Mar 2018 (T+90)
- 20,000 shares@ US$1.525.3% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:0
- 20,000 shares@ US$1.605.6% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:1
- 60,000 shares@ US$2.6727.9% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:2
- 52,139 shares@ US$2.6724.3% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:3
- 20,000 shares@ US$1.455.1% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:4
- 20,000 shares@ US$1.645.7% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:5
- 20,000 shares@ US$1.515.3% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:6
- 18,361 shares@ US$1.815.8% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:7
- 20,000 shares@ US$1.695.9% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:8
- 20,000 shares@ US$2.207.7% of flowCommon Stock, $0.0001 par value per shareSEC:0001144204-16-136387:9
- 5,000 shares@ US$2.17Common Stock, par value $0.0001 per shareSEC:0001144204-11-048618:0Canonical exit: 16 Nov 2011 (T+90)
- 10,000 shares@ US$13.25Common StockSEC:0001179110-11-011516:0
- 10,000 shares@ US$15.02Common StockSEC:0001179110-11-010960:0
- 10,000 shares@ US$11.70Common StockSEC:0001179110-11-010115:0
- 10,000 shares@ US$11.69Common StockSEC:0001179110-11-009520:0
- 10,000 shares@ US$12.24Common StockSEC:0001179110-11-008828:0
- 10,000 shares@ US$13.23Common StockSEC:0001179110-11-007995:0
- 20,000 shares@ US$13.28Common StockSEC:0001179110-11-007121:0
- 20,000 shares@ US$12.11Common StockSEC:0001179110-11-006537:0
- 25,000 shares@ US$8.92Common StockSEC:0001179110-11-005717:0
- 25,000 shares@ US$8.50Common StockSEC:0001179110-11-005255:0
- 81,359 shares@ US$6.78Common StockSEC:0001179110-09-015810:0
- 73,000 shares@ US$8.05Common StockSEC:0001179110-09-015810:1
25 of 90 declarations
